Comparative analysis of antibody induction and protection against influenza virus infection by DNA immunization with HA, HAe, and HA1 in mice

[1]  Hongjun Li,et al.  Influenza A (H1N1) , 2015, Radiology of Infectious Diseases: Volume 1.

[2]  D. W. Kim,et al.  Sublingual administration of bacteria-expressed influenza virus hemagglutinin 1 (HA1) induces protection against infection with 2009 pandemic H1N1 influenza virus , 2013, Journal of Microbiology.

[3]  G. Kobinger,et al.  A Single Electroporation Delivery of a DNA Vaccine Containing the Hemagglutinin Gene of Asian H5N1 Avian Influenza Virus Generated a Protective Antibody Response in Chickens against a North American Virus Strain , 2013, Clinical and Vaccine Immunology.

[4]  M. Steensels,et al.  Potency of a Recombinant NDV-H5 Vaccine Against Various HPAI H5N1 Virus Challenges in SPF Chickens , 2012, Avian diseases.

[5]  Jie Zhou,et al.  A Recombinant Vaccine of H5N1 HA1 Fused with Foldon and Human IgG Fc Induced Complete Cross-Clade Protection against Divergent H5N1 Viruses , 2011, PloS one.

[6]  S. Khurana,et al.  Bacterial HA1 Vaccine against Pandemic H5N1 Influenza Virus: Evidence of Oligomerization, Hemagglutination, and Cross-Protective Immunity in Ferrets , 2010, Journal of Virology.

[7]  A. García-Sastre,et al.  Variations in the Hemagglutinin of the 2009 H1N1 Pandemic Virus: Potential for Strains with Altered Virulence Phenotype? , 2010, PLoS pathogens.

[8]  S. Khurana,et al.  Properly Folded Bacterially Expressed H1N1 Hemagglutinin Globular Head and Ectodomain Vaccines Protect Ferrets against H1N1 Pandemic Influenza Virus , 2010, PloS one.

[9]  R. Webster,et al.  Adaptation of Pandemic H1N1 Influenza Viruses in Mice , 2010, Journal of Virology.

[10]  John Steel,et al.  Influenza Virus Vaccine Based on the Conserved Hemagglutinin Stalk Domain , 2010, mBio.

[11]  A. Osterhaus,et al.  Introduction of Virulence Markers in PB2 of Pandemic Swine-Origin Influenza Virus Does Not Result in Enhanced Virulence or Transmission , 2010, Journal of Virology.

[12]  Xiaofeng Liang,et al.  Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: a multicentre, double-blind, randomised, placebo-controlled trial , 2010, The Lancet.

[13]  K. Hoschler,et al.  Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccine. , 2009, The New England journal of medicine.

[14]  X. Zhang,et al.  A novel influenza A (H1N1) vaccine in various age groups. , 2009, The New England journal of medicine.

[15]  C. Wichems,et al.  Response to a monovalent 2009 influenza A (H1N1) vaccine. , 2009, The New England journal of medicine.

[16]  Libo Dong,et al.  Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. , 2009, The New England journal of medicine.

[17]  E. Ramsburg,et al.  Intramuscular immunization with a vesicular stomatitis virus recombinant expressing the influenza hemagglutinin provides post-exposure protection against lethal influenza challenge. , 2009, Vaccine.

[18]  L. Finelli,et al.  Emergence of a novel swine-origin influenza A (H1N1) virus in humans. , 2009, The New England journal of medicine.

[19]  T. Kuiken,et al.  Preclinical evaluation of a modified vaccinia virus Ankara (MVA)-based vaccine against influenza A/H5N1 viruses. , 2009, Vaccine.

[20]  Guang Zeng,et al.  Lack of Airborne Transmission during Outbreak of Pandemic (H1N1) 2009 among Tour Group Members, China, June 2009 , 2009, Emerging infectious diseases.

[21]  Hideo Goto,et al.  In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses , 2009, Nature.

[22]  Marion Koopmans,et al.  Pathogenesis and Transmission of Swine-Origin 2009 A(H1N1) Influenza Virus in Ferrets , 2009, Science.

[23]  Ron A M Fouchier,et al.  Antigenic and Genetic Characteristics of Swine-Origin 2009 A(H1N1) Influenza Viruses Circulating in Humans , 2009, Science.

[24]  Rahul Raman,et al.  Transmission and Pathogenesis of Swine-Origin 2009 A(H1N1) Influenza Viruses in Ferrets and Mice , 2009, Science.

[25]  Gavin J. D. Smith,et al.  Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic , 2009, Nature.

[26]  E. Lyons,et al.  Pandemic Potential of a Strain of Influenza A (H1N1): Early Findings , 2009, Science.

[27]  J. Oxford,et al.  DNA vaccination protects against an influenza challenge in a double-blind randomised placebo-controlled phase 1b clinical trial. , 2009, Vaccine.

[28]  D. Tang,et al.  Protection of chickens against avian influenza with nonreplicating adenovirus-vectored vaccine. , 2009, Poultry science.

[29]  A. García-Sastre,et al.  Human HA and polymerase subunit PB2 proteins confer transmission of an avian influenza virus through the air , 2009, Proceedings of the National Academy of Sciences.

[30]  Jianjun Chen,et al.  A single immunization with HA DNA vaccine by electroporation induces early protection against H5N1 avian influenza virus challenge in mice , 2009, BMC infectious diseases.

[31]  John Steel,et al.  Transmission of Influenza Virus in a Mammalian Host Is Increased by PB2 Amino Acids 627K or 627E/701N , 2009, PLoS pathogens.

[32]  L. Balluz,et al.  Effectiveness of 2008-09 trivalent influenza vaccine against 2009 pandemic influenza A (H1N1) - United States, May-June 2009. , 2009, MMWR. Morbidity and mortality weekly report.

[33]  Robert Schechter,et al.  Swine influenza A (H1N1) infection in two children--Southern California, March-April 2009. , 2009, MMWR. Morbidity and mortality weekly report.

[34]  F. Fang,et al.  Comparing the ability of a series of viral protein-expressing plasmid DNAs to protect against H5N1 influenza virus , 2009, Virus Genes.

[35]  W. Hong,et al.  Comparing the antibody responses against recombinant hemagglutinin proteins of avian influenza A (H5N1) virus expressed in insect cells and bacteria , 2008, Journal of medical virology.

[36]  J. Kwang,et al.  Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant. , 2008, Virology.

[37]  Yu Zhou,et al.  Electroporation at Low Voltages Enables DNA Vaccine to Provide Protection against a Lethal H5N1 Avian Influenza Virus Challenge in Mice , 2008, Intervirology.

[38]  Lucy A. Perrone,et al.  A Single Mutation in the PB1-F2 of H5N1 (HK/97) and 1918 Influenza A Viruses Contributes to Increased Virulence , 2007, PLoS pathogens.

[39]  D. Weiner,et al.  Immunogenicity of novel consensus-based DNA vaccines against avian influenza. , 2007, Vaccine.

[40]  Huálín Wáng,et al.  Protection against avian influenza H9N2 virus challenge by immunization with hemagglutinin- or neuraminidase-expressing DNA in BALB/c mice. , 2006, Biochemical and biophysical research communications.

[41]  Shuhan Sun,et al.  Essential sequence of influenza neuraminidase DNA to provide protection against lethal viral infection. , 2006, DNA and cell biology.

[42]  D. Suarez,et al.  Development and Application of Reference Antisera against 15 Hemagglutinin Subtypes of Influenza Virus by DNA Vaccination of Chickens , 2006, Clinical and Vaccine Immunology.

[43]  Jianjun Chen,et al.  Protection against influenza virus infection in BALB/c mice immunized with a single dose of neuraminidase-expressing DNAs by electroporation. , 2005, Vaccine.

[44]  K. Karaca,et al.  Assessment of the efficacy of a single dose of a recombinant vaccine against West Nile virus in response to natural challenge with West Nile virus-infected mosquitoes in horses. , 2004, American journal of veterinary research.

[45]  M. Itoh,et al.  Analysis of epitope recognition of antibodies induced by DNA immunization against hemagglutinin protein of influenza A virus. , 2003, Vaccine.

[46]  C. Secombes,et al.  DNA vaccination against viral haemorrhagic septicaemia (VHS) in rainbow trout: size, dose, route of injection and duration of protection-early protection correlates with Mx expression. , 2003, Fish & shellfish immunology.

[47]  J. Rousset,et al.  Strategies to Improve Protection Against Low-Pathogenicity H7 Avian Influenza Virus Infection Using DNA Vaccines , 2003, Avian diseases.

[48]  L. Babiuk,et al.  Electroporation improves the efficacy of DNA vaccines in large animals. , 2002, Vaccine.

[49]  A. Osterhaus,et al.  DNA vaccination of ferrets with chimeric influenza A virus hemagglutinin (H3) genes. , 2002, Vaccine.

[50]  G. Sachdeva,et al.  Plasmid DNA immunization against Japanese encephalitis virus: immunogenicity of membrane-anchored and secretory envelope protein. , 2002, The Journal of infectious diseases.

[51]  Yoshihiro Kawaoka,et al.  Molecular Basis for High Virulence of Hong Kong H5N1 Influenza A Viruses , 2001, Science.

[52]  S. Gurunathan,et al.  DNA vaccines: immunology, application, and optimization*. , 2000, Annual review of immunology.

[53]  H. Robinson,et al.  DNA immunization: effect of secretion of DNA-expressed hemagglutinins on antibody responses. , 1999, Vaccine.

[54]  L. Babiuk,et al.  Altering the Cellular Location of an Antigen Expressed by a DNA-Based Vaccine Modulates the Immune Response , 1999, Journal of Virology.

[55]  R. Webster,et al.  DNA Vaccine Encoding Hemagglutinin Provides Protective Immunity against H5N1 Influenza Virus Infection in Mice , 1999, Journal of Virology.

[56]  T. Iwasaki,et al.  Comparison of the ability of viral protein-expressing plasmid DNAs to protect against influenza. , 1998, Vaccine.

[57]  H. Aihara,et al.  Gene transfer into muscle by electroporation in vivo. , 1998, Nature biotechnology.

[58]  K. Mozdzanowska,et al.  A pulmonary influenza virus infection in SCID mice can be cured by treatment with hemagglutinin-specific antibodies that display very low virus-neutralizing activity in vitro , 1997, Journal of virology.

[59]  L. Reed,et al.  A SIMPLE METHOD OF ESTIMATING FIFTY PER CENT ENDPOINTS , 1938 .